Substrates dissociate dopamine transporter oligomers

Journal of Neurochemistry

Volumn 105, Issue 3, 2008, Pages 910-920

  Chen, Nianhang ^a   Reith, Maarten E A ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Amphetamine; Coimmunoprecipitation; Cross linking; Dopamine transporter; Oligomerization; Substrates

Indexed keywords

AMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; MYC PROTEIN; OLIGOMER;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOTINYLATION; CELL SURFACE; CONTROLLED STUDY; CROSS LINKING; DRUG EFFECT; DRUG INHIBITION; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR WEIGHT; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

AMPHETAMINE; BINDING SITES; BRAIN; BRAIN CHEMISTRY; CELL LINE; DIMERIZATION; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENDOCYTOSIS; HUMANS; NEURONS; PROTEIN BINDING;

EID: 42449094246     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05195.x     Document Type: Article

References (48)

1. Aramburu J., Drews-Elger K., Estrada-Gelonch A., Minguillon J., Morancho B., Santiago V. Lopez-Rodriguez C. (2006) Regulation of the hypertonic stress response and other cellular functions by the Rel-like transcription factor NFAT5. Biochem. Pharmacol. 72, 1597 1604.
2. Balasubramanian S., Teissere J. A., Raju D. V. Hall R. A. (2004) Hetero-oligomerization between GABAA and GABAB receptors regulates GABAB receptor trafficking. J. Biol. Chem. 279, 18840 18850.
3. Berger S. P., Farrell K., Conant D., Kempner E. S. Paul S. M. (1994) Radiation inactivation studies of the dopamine reuptake transporter protein. Mol. Pharmacol. 46, 726 731.
4. Bungay P. M., Newton-Vinson P., Isele W., Garris P. A. Justice J. B. (2003) Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J. Neurochem. 86, 932 946.
5. Chen K. C. (2006) Effects of tissue trauma on the characteristics of microdialysis zero-net-flux method sampling neurotransmitters. J. Theor. Biol. 238, 863 881.
6. Chen N. Reith M. E. A. (2002) Structure-function relationships for biogenic amine neurotransmitter transporters, in Neurotransmitter Transporters: Structure, Function, and Regulation (Reith M. E. A., ed pp. 53 109. Humana Press, Totowa, NJ.
7. Chen N., Zhen J. Reith M. E. A. (2004) Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR 12909 and benztropine as opposed to cocaine. J. Neurochem. 89, 853 864.
8. Chi L. Reith M. E. A. (2003) Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. J. Pharmacol. Exp. Ther. 307, 729 736.
9. Cragg S. J. Rice M. E. (2004) DAncing past the DAT at a DA synapse. Trends Neurosci. 27, 270 277.
10. Daniels G. M. Amara S. G. (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274, 35794 35801.
11. Daws L. C., Callaghan P. D., Moron J. A., Kahlig K. M., Shippenberg T. S., Javitch J. A. Galli A. (2002) Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem. Biophys. Res. Commun. 290, 1545 1550.
12. Fiorentini C., Gardoni F., Spano P., Di L. M. Missale C. (2003) Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J. Biol. Chem. 278, 20196 20202.
13. Genedani S., Guidolin D., Leo G., Filaferro M., Torvinen M., Woods A. S., Fuxe K., Ferre S. Agnati L. F. (2005) Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers. J. Mol. Neurosci. 26, 177 184.
14. Gnegy M. E. (2003) The effect of phosphorylation on amphetamine-mediated outward transport. Eur. J. Pharmacol. 479, 83 91.
15. Gulley J. M., Doolen S. Zahniser N. R. (2002) Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J. Neurochem. 83, 400 411.
16. Hastrup H., Karlin A. Javitch J. A. (2001) Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc. Natl Acad. Sci. USA 98, 10055 10060.
17. Hastrup H., Sen N. Javitch J. A. (2003) The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs. J. Biol. Chem. 278, 45045 45048.
18. Holton K. L., Loder M. K. Melikian H. E. (2005) Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat. Neurosci. 8, 881 888.
19. Jones S. R., Gainetdinov R. R., Wightman R. M. Caron M. G. (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 1979 1986.
20. Kahlig K. M., Javitch J. A. Galli A. (2004) Amphetamine regulation of dopamine transport: combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier. J. Biol. Chem. 279, 8966 8975.
21. Kahlig K. M., Lute B. J., Wei Y., Loland C. J., Gether U., Javitch J. A. Galli A. (2006) Regulation of dopamine transporter trafficking by intracellular amphetamine. Mol. Pharmacol. 70, 542 548.
22. Kamal L. A., Arbilla S., Galzin A. M. Langer S. Z. (1983) Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate. J. Pharmacol. Exp. Ther. 227, 446 458.
23. Kilic F. Rudnick G. (2000) Oligomerization of serotonin transporter and its functional consequences. Proc. Natl Acad. Sci. USA 97, 3106 3111.
24. Kocabas A. M., Rudnick G. Kilic F. (2003) Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters. J. Neurochem. 85, 1513 1520.
25. Koenig J. A. Edwardson J. M. (1997) Endocytosis and recycling of G protein-coupled receptors. Trends Pharmacol. Sci. 18, 276 287.
26. Kuczenski R. Segal D. S. (1992) Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther. 262, 1085 1094.
27. Li L. B., Chen N., Ramamoorthy S., Chi L., Cui X. N., Wang L. C. Reith M. E. (2004) The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J. Biol. Chem. 279, 21012 21020.
28. Little K. Y., Elmer L. W., Zhong H., Scheys J. O. Zhang L. (2002) Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol. Pharmacol. 61, 436 445.
29. Loder M. K. Melikian H. E. (2003) The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J. Biol. Chem. 278, 22168 22174.
30. Loo T. W., Bartlett M. C. Clarke D. M. (2004) Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane. J. Biol. Chem. 279, 7692 7697.
31. Milner H. E., Beliveau R. Jarvis S. M. (1994) The in situ size of the dopamine transporter is a tetramer as estimated by radiation inactivation. Biochim. Biophys. Acta 1190, 185 187.
32. Miranda M., Dionne K. R., Sorkina T. Sorkin A. (2007) Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter. Mol. Biol. Cell 18, 313 323.
33. Missale C., Fiorentini C., Busi C., Collo G. Spano P. F. (2006) The NMDA/D1 receptor complex as a new target in drug development. Curr. Top. Med. Chem. 6, 801 808.
34. Oda M., Sakitani K., Kaibori M., Inoue T., Kamiyama Y. Okumura T. (2000) Vicinal dithiol-binding agent, phenylarsine oxide, inhibits inducible nitric-oxide synthase gene expression at a step of nuclear factor-kappaB DNA binding in hepatocytes. J. Biol. Chem. 275, 4369 4373.
35. Reith M. E. A., Jacobson A. E., Rice K. C., Benuck M. Zimanyi I. (1991) Effect of metaphit on dopaminergic neurotransmission in rat striatal slices: involvement of the dopamine transporter and voltage-dependent sodium channel. J. Pharmacol. Exp. Ther. 259, 1188 1196.
36. Sattler R. Rothstein J. D. (2006) Regulation and dysregulation of glutamate transporters. Handb. Exp. Pharmacol. 175, 277 303.
37. Saunders C., Ferrer J. V., Shi L., Chen J., Merrill G., Lamb M. E., Leeb-Lundberg L. M., Carvelli L., Javitch J. A. Galli A. (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc. Natl Acad. Sci. USA 97, 6850 6855.
38. Schmid J. A., Scholze P., Kudlacek O., Freissmuth M., Singer E. A. Sitte H. H. (2001) Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells. J. Biol. Chem. 276, 3805 3810.
39. Seidel S., Singer E. A., Just H. et al. (2005) Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol. Pharmacol. 67, 140 151.
40. Shvetsov A., Musib R., Phillips M., Rubenstein P. A. Reisler E. (2002) Locking the hydrophobic loop 262-274 to G-actin surface by a disulfide bridge prevents filament formation. Biochemistry 41, 10787 10793.
41. Sitte H. H., Huck S., Reither H., Boehm S., Singer E. A. Pifl C. (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J. Neurochem. 71, 1289 1297.
42. Sitte H. H., Farhan H. Javitch J. A. (2004) Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. Mol. Intervent. 4, 38 47.
43. Sorkina T., Doolen S., Galperin E., Zahniser N. R. Sorkin A. (2003) Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy. J. Biol. Chem. 278, 28274 28283.
44. Sorkina T., Hoover B. R., Zahniser N. R. Sorkin A. (2005) Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6, 157 170.
45. Stanasila L., Perez J. B., Vogel H. Cotecchia S. (2003) Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization. J. Biol. Chem. 278, 40239 40251.
46. Sulzer D., Sonders M. S., Poulsen N. W. Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406 433.
47. Torres G. E., Carneiro A., Seamans K., Fiorentini C., Sweeney A., Yao W. D. Caron M. G. (2003) Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J. Biol. Chem. 278, 2731 2739.
48. Wall S. C., Gu H. Rudnick G. (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol. Pharmacol. 47, 544 550.